Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

SEC Filings

Filing date Form Description Filing Group View
D
Other
View HTML
D
Other
View HTML
PREM14A

A preliminary proxy statement relating to a merger or acquisition

Mergers & Acquisitions
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML